Cookson Peirce & Co’s 10x Genomics TXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$6.18M Sell
68,359
-11,953
-15% -$699K 0.22% 73
2026
Q2
$3.08M Buy
80,312
+50,312
+168% +$1.32M 0.1% 95
2026
Q1
$637K Sell
30,000
-5,000
-14% -$100K 0.03% 220
2025
Q4
$571K Buy
+35,000
New +$529K 0.02% 231
2025
Q3
– Sell
-25,000
Closed -$290K – 351
2025
Q2
$290K Buy
+25,000
New +$228K 0.01% 244
2021
Q2
– Sell
-17,835
Closed -$3.23M – 234
2021
Q1
$3.23M Buy
+17,835
New +$3.08M 0.21% 71

Other funds holding TXG

Cookson Peirce & Co's TXG Position: Q3 2026 in Review

Cookson Peirce & Co reduced its 10x Genomics (TXG) stake by 15% in Q3 2026, selling an estimated $699K and leaving 68,359 shares worth $6.18M. The position accounts for 0.22% of the portfolio, ranked #73.

Cookson Peirce & Co first reported a position in TXG in Q1 2021 and has held it in 6 quarters since. 483 funds tracked by Wall St. Rank hold TXG as of Q3 2026.

  • Cookson Peirce & Co held 68,359 shares of 10x Genomics worth $6.18M as of Q3 2026.
  • Cookson Peirce & Co sold 11,953 10x Genomics shares in Q3 2026, an estimated $699K.
  • 10x Genomics made up 0.22% of Cookson Peirce & Co's portfolio in Q3 2026, its #73 holding.
  • Cookson Peirce & Co first reported a position in 10x Genomics in Q1 2021 and has held it in 6 quarters since.
  • 483 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2026.

Based on Cookson Peirce & Co's 13F filing for Q3 2026, filed 30 Oct 2026.